NCT00230620View on ClinicalTrials.gov

Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

December 31, 1998

Primary Completion Date

April 30, 2030

Study Completion Date

April 30, 2030

Conditions
Telangiectasia, Hereditary Hemorrhagic
Trial Locations (1)

W12 0NN

RECRUITING

Imperial College Hammersmith Campus, London

All Listed Sponsors
collaborator

British Heart Foundation

OTHER

lead

Imperial College London

OTHER

NCT00230620 - Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families | Biotech Hunter | Biotech Hunter